The longest screening study on prostate cancer shows blood test measuring the levels of PSA, a well-known marker of prostate cancer, cuts deaths from the disease by nearly 30%.  The study followed 20,000 men in Sweden for more than two decades and was featured in Maria Franlund’s PhD thesis.  

Read the full article: Study Shows PSA Testing Cuts Deaths